OTSU Pharmaceuticals: Major
Health Technology
Mkt Cap
3.4B
P/E (TTM)
9.88
EPS
2.29
ROE
38.45%
Div Yield
5 years
FY2025FY2024FY2023FY2022FY2021
Profitability
Return on Equity (ROE)4.04%-0.69%-1.02%38.19%125.07%
Return on Assets (ROA)1.14%-0.21%-0.35%13.92%24.36%
Return on Invested Capital4.00%-0.68%-1.01%37.12%118.93%
Gross Margin22.05%17.68%21.17%31.33%31.70%
Operating Margin6.78%-0.24%5.30%15.00%16.77%
EBITDA Margin8.97%2.94%8.53%18.53%20.57%
Net Margin0.73%-0.15%-0.24%8.13%15.17%
Pre-Tax Margin2.85%0.58%-0.43%12.79%18.44%
Liquidity
Current Ratio0.991.071.101.311.12
Quick Ratio0.350.400.360.350.41
Leverage
Debt / Equity1.561.441.370.700.81
Debt / Assets0.430.430.420.270.27
LT Debt / Equity0.000.020.010.000.06
LT Debt / Assets0.000.010.000.000.02
Net Debt704.68M664.57M936.88M447.29M360.49M
Total Debt1.08B976.22M957.32M500.50M405.00M
Efficiency
Asset Turnover1.561.381.481.711.61
Inventory Turnover2.612.322.122.222.35
Per Share
Book Value Per Share57.5055.8457.6558.9341.40
Tangible Book Per Share57.4755.7857.5658.7741.28
Cash Per Share31.3125.761.694.403.68
Total Debt Per Share89.5580.6879.1241.3633.47
Working Capital Per Share-1.189.0613.4729.109.75
Shares & Market
Total Shares Outstanding12,100,00012,100,00012,100,00012,100,00012,100,000
Market Cap3.56B1.42B876.04M2.94B3.63B
Enterprise Value4.27B2.08B1.81B3.39B3.99B
Employees408345362373375
Shareholders1,5491,5491,5491,5491,549